Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression

Area of Science:

• Cancer Biology
• Stem Cell Research
• Molecular Oncology

Background:

• Limited availability of melanoma stem cells hinders therapeutic reagent screening and molecular mechanism studies.
• Induced expression of Oct4, Sox2, Klf4, and c-Myc can convert other cancer cells into stem cells.

Purpose of the Study:

• To investigate if the four stem cell factors can transform melanoma cells into melanoma stem cells (MSCs).
• To identify the molecular signaling pathways involved in this phenotypic transformation.

Main Methods:

• Melanoma B16-F10 cells were transfected with a plasmid encoding the four factors (Oct4, Sox2, Klf4, c-Myc) under a Tet-On system.
• Doxycycline (DOX) was used to induce factor expression.
• Assessed changes in tumor-initiating cell populations in vitro and in vivo.
• Analyzed mRNA expression of signal transducer and activator of transcription 3 (Stat3).

Main Results:

• Stable melanoma cell clones successfully expressed the four transcription factors upon DOX induction.
• Induced expression of these factors remodeled melanoma cells into melanoma stem cells (MSCs).
• Increased numbers of tumor-initiating cells (MSCs) were observed both in vitro and in vivo.
• mRNA levels of signal transducer and activator of transcription 3 (Stat3) were exclusively increased.

Conclusions:

• Phenotypic remodeling of melanoma cells using the four factors offers a method for generating melanoma stem cells (MSCs).
• Stat3 signaling is implicated as a key mediator in the transformation process, suggesting it as a potential therapeutic target for melanoma.